These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23356844)
1. In-vitro and in-vivo evaluation of austocystin D liposomes. Li S; Hu J; Zhang L; Zhang L; Sun Y; Xie Y; Wu S; Liu L; Gao Z J Pharm Pharmacol; 2013 Mar; 65(3):355-62. PubMed ID: 23356844 [TBL] [Abstract][Full Text] [Related]
2. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers. Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938 [TBL] [Abstract][Full Text] [Related]
3. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582 [TBL] [Abstract][Full Text] [Related]
4. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization. Vaidya B; Vyas SP J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366 [TBL] [Abstract][Full Text] [Related]
5. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation. Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070 [TBL] [Abstract][Full Text] [Related]
6. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides. Hu K; Zhu L; Liang H; Hu F; Feng J Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810 [TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer. Ye H; Liu X; Sun J; Zhu S; Zhu Y; Chang S BMC Cancer; 2016 Oct; 16(1):831. PubMed ID: 27793127 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models. Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116 [TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes. Sun W; Zhang N; Li A; Zou W; Xu W Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370 [TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094 [TBL] [Abstract][Full Text] [Related]
11. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801 [TBL] [Abstract][Full Text] [Related]
13. [Preparation and quality evaluation of Iohexol liposomes]. Zhou R; Zhu X; Hung G; Zhang N; Zhang B Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):918-22. PubMed ID: 17899774 [TBL] [Abstract][Full Text] [Related]
14. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo. Zalba S; Navarro I; Trocóniz IF; Tros de Ilarduya C; Garrido MJ Eur J Pharm Biopharm; 2012 Jun; 81(2):273-80. PubMed ID: 22369879 [TBL] [Abstract][Full Text] [Related]
15. [Preparation and in vitro and in vivo study of antisense oligodeoxynucleotides-loaded cationic liposomes]. Liu Y; Zhang ZZ; Li K; Mei Q Yao Xue Xue Bao; 2009 Nov; 44(11):1273-7. PubMed ID: 21355327 [TBL] [Abstract][Full Text] [Related]
16. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan. Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756 [TBL] [Abstract][Full Text] [Related]
17. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate. Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128 [TBL] [Abstract][Full Text] [Related]
18. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Wang Z; Yu Y; Dai W; Lu J; Cui J; Wu H; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Nov; 33(33):8451-60. PubMed ID: 22940213 [TBL] [Abstract][Full Text] [Related]
19. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. Marra M; Salzano G; Leonetti C; Porru M; Franco R; Zappavigna S; Liguori G; Botti G; Chieffi P; Lamberti M; Vitale G; Abbruzzese A; La Rotonda MI; De Rosa G; Caraglia M Biotechnol Adv; 2012; 30(1):302-9. PubMed ID: 21741464 [TBL] [Abstract][Full Text] [Related]
20. Tumor imaging and interferon-γ-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice. Zhuo H; Peng Y; Yao Q; Zhou N; Zhou S; He J; Fang Y; Li X; Jin H; Lu X; Zhao Y Clin Cancer Res; 2013 Aug; 19(15):4206-17. PubMed ID: 23759675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]